Today, Congresswoman Lizzie Fletcher (TX-07) released her 2023 Annual Report detailing her work representing Texas’ Seventh Congressional District this year. The report highlights Congresswoman Fletcher’s work on legislation, events in the district, congressional work in DC, and constituent matters.
“I am honored and proud to represent Texas’ Seventh Congressional District, and to bring the voices of those who live and work here to the national conversation about the challenges and opportunities before us,” said Congresswoman Lizzie Fletcher. “I am glad to share some of the highlights of this work in my 2023 Annual Report, and I look forward to continuing my work for our community and our country ahead.”
Highlights of the 2023 Annual Report include:
Constituent Advocacy: This year, Congresswoman Fletcher’s office resolved more than 3,000 constituent matters, and reached the milestone of resolving more than 12,000 constituent matters since she assumed office.
Regional Leadership Council: House Democratic Leader Hakeem Jeffries appointed Congresswoman Fletcher to the Regional Leadership Council where she works with President Biden and his administration on implementation of the historic legislation passed in the 117th Congress, including the Infrastructure Investment and Jobs Act, Bipartisan Safer Communities Act, the CHIPS and Science Act, and more.
Legislation: Congresswoman Fletcher has introduced several bills in the House of Representatives this year, including:
the Ensuring Women’s Right to Reproductive Freedom Act, H.R. 782, to protect the constitutional right to travel across state lines, including for reproductive health care;
the Connecting Our Medical Providers with Links To Expand Tailored and Effective (COMPLETE) Care Act, H.R. 5819, to help primary care providers improve mental health care access for Medicare beneficiaries in primary care settings;
the Toxic-Free Beauty Act, H.R. 3619, which prohibits the use of certain hazardous chemicals from personal and professional care, beauty, and salon products sold in the U.S.; and
the Strengthening Community Care Act, H.R. 2559, to reauthorize federal funding for Community Health Centers and the National Health Service Corps through 2028.
